| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0.001 | 0.949 | Angiotensin-converting enzyme inhibitor | 0.681 0.002 DBMET00803 | ||
| 0.812 | 0.001 | 0.812 | Leukotriene A4 hydrolase inhibitor | 0.708 0.002 DBMET00803 | ||
| 0.7 | 0.004 | 0.7 | Diuretic | 0.432 0.011 DBMET00803 | ||
| 0.626 | 0.002 | 0.626 | Aminopeptidase B inhibitor | 0.62 0.002 DBMET00803 | ||
| 0.558 | 0.01 | 0.558 | Vasodilator, coronary | 0.373 0.045 DBMET00803 | ||
| 0.555 | 0.008 | 0.622 | Vasodilator | 0.622 0.005 DBMET00803 | DBMET00803 | |
| 0.465 | 0.002 | 0.465 | Neutral endopeptidase inhibitor | 0.203 0.003 DBMET00803 | ||
| 0.427 | 0.001 | 0.427 | Lysine carboxypeptidase inhibitor | 0.265 0.002 DBMET00803 | ||
| 0.456 | 0.039 | 0.456 | Aldehyde oxidase inhibitor | |||
| 0.421 | 0.025 | 0.421 | Cardiotonic | 0.317 0.049 DBMET00803 | ||
| 0.393 | 0.002 | 0.393 | Angiotensin-converting enzyme 2 inhibitor | 0.13 0.003 DBMET00803 | ||
| 0.421 | 0.044 | 0.561 | Immunostimulant | 0.561 0.021 DBMET00803 | DBMET00803 | |
| 0.383 | 0.013 | 0.383 | Thrombolytic | 0.321 0.02 DBMET00803 | ||
| 0.385 | 0.025 | 0.385 | Insulysin inhibitor | 0.349 0.035 DBMET00803 | ||
| 0.384 | 0.033 | 0.384 | Interleukin antagonist | |||
| 0.323 | 0.003 | 0.323 | Aminopeptidase I inhibitor | 0.286 0.003 DBMET00803 | ||
| 0.32 | 0.008 | 0.32 | Succinate dehydrogenase inhibitor | 0.2 0.049 DBMET00803 | ||
| 0.309 | 0.005 | 0.309 | Alcohol dehydrogenase inhibitor | 0.193 0.013 DBMET00803 | ||
| 0.301 | 0.003 | 0.301 | Endothelin-converting enzyme inhibitor | 0.112 0.013 DBMET00803 | ||
| 0.337 | 0.052 | 0.414 | Interleukin 2 agonist | 0.414 0.023 DBMET00803 | DBMET00803 | |
| 0.368 | 0.092 | 0.368 | Antibacterial | 0.296 0.139 DBMET00803 | ||
| 0.303 | 0.048 | 0.303 | Angiogenesis stimulant | 0.302 0.049 DBMET00803 | ||
| 0.262 | 0.01 | 0.262 | Neurotrophic factor | 0.247 0.013 DBMET00803 | ||
| 0.292 | 0.054 | 0.487 | Antiamyloidogenic | 0.487 0.017 DBMET00803 | DBMET00803 | |
| 0.285 | 0.056 | 0.285 | Superoxide dismutase inhibitor | 0.279 0.059 DBMET00803 | ||
| 0.228 | 0.009 | 0.296 | Mucolytic | 0.296 0.004 DBMET00803 | DBMET00803 | |
| 0.297 | 0.088 | 0.327 | Apoptosis antagonist | 0.327 0.068 DBMET00803 | DBMET00803 | |
| 0.285 | 0.076 | 0.285 | Spasmolytic | 0.203 0.117 DBMET00803 | ||
| 0.222 | 0.016 | 0.301 | Expectorant | 0.301 0.008 DBMET00803 | DBMET00803 | |
| 0.23 | 0.025 | 0.254 | Neurotensin receptor agonist | 0.254 0.02 DBMET00803 | DBMET00803 | |
| 0.225 | 0.032 | 0.225 | Phospholipase C inhibitor | 0.202 0.042 DBMET00803 | ||
| 0.287 | 0.097 | 0.462 | Antithrombotic | 0.462 0.035 DBMET00803 | DBMET00803 | |
| 0.231 | 0.043 | 0.265 | Anticoagulant | 0.265 0.035 DBMET00803 | DBMET00803 | |
| 0.192 | 0.01 | 0.442 | Analgesic, opioid | 0.442 0.004 DBMET00803 | DBMET00803 | |
| 0.213 | 0.04 | 0.213 | Amylase inhibitor | |||
| 0.246 | 0.084 | 0.254 | Gastrin inhibitor | 0.254 0.075 DBMET00803 | DBMET00803 | |
| 0.162 | 0.006 | 0.282 | Aminopeptidase microsomal inhibitor | 0.282 0.003 DBMET00803 | DBMET00803 | |
| 0.173 | 0.021 | 0.195 | Catalase inhibitor | 0.195 0.016 DBMET00803 | DBMET00803 | |
| 0.159 | 0.014 | 0.166 | Glutamate dehydrogenase inhibitor | 0.166 0.013 DBMET00803 | DBMET00803 | |
| 0.14 | 0.001 | 0.421 | Aminopeptidase A inhibitor | 0.421 0.001 DBMET00803 | DBMET00803 | |
| 0.141 | 0.006 | 0.26 | Aminopeptidase N inhibitor | 0.26 0.003 DBMET00803 | DBMET00803 | |
| 0.179 | 0.049 | 0.202 | Insulin secretagoues | 0.202 0.035 DBMET00803 | DBMET00803 | |
| 0.171 | 0.044 | 0.171 | Alpha-N-acetylglucosaminidase inhibitor | 0.136 0.064 DBMET00803 | ||
| 0.138 | 0.015 | 0.138 | Matrix metalloproteinase inhibitor | |||
| 0.137 | 0.017 | 0.142 | Somatostatin 1 agonist | 0.142 0.016 DBMET00803 | DBMET00803 | |
| 0.132 | 0.017 | 0.165 | Glutamate decarboxylase inhibitor | 0.165 0.01 DBMET00803 | DBMET00803 | |
| 0.117 | 0.003 | 0.117 | Peptide deformylase inhibitor | 0.027 0.026 DBMET00803 | ||
| 0.214 | 0.102 | 0.214 | DNA synthesis inhibitor | 0.173 0.164 DBMET00803 | ||
| 0.177 | 0.066 | 0.177 | Peroxidase inhibitor | 0.113 0.107 DBMET00803 | ||
| 0.211 | 0.103 | 0.211 | Calpain inhibitor | |||
| 0.184 | 0.076 | 0.337 | Hepatoprotectant | 0.337 0.021 DBMET00803 | DBMET00803 | |
| 0.119 | 0.013 | 0.222 | Ornithine carbamoyltransferase inhibitor | 0.222 0.006 DBMET00803 | DBMET00803 | |
| 0.103 | 0.004 | 0.114 | Arginase inhibitor | 0.114 0.003 DBMET00803 | DBMET00803 | |
| 0.105 | 0.005 | 0.105 | Prolyl endopeptidase inhibitor | 0.089 0.008 DBMET00803 | ||
| 0.209 | 0.113 | 0.299 | Interleukin agonist | 0.299 0.048 DBMET00803 | DBMET00803 | |
| 0.101 | 0.009 | 0.125 | Leukocyte elastase inhibitor | 0.125 0.007 DBMET00803 | DBMET00803 | |
| 0.156 | 0.064 | 0.156 | Protein kinase stimulant | |||
| 0.208 | 0.122 | 0.29 | Tyrosine 3 hydroxylase inhibitor | 0.29 0.038 DBMET00803 | DBMET00803 | |
| 0.105 | 0.02 | 0.105 | Neutrophil collagenase inhibitor | |||
| 0.09 | 0.007 | 0.09 | HCV NS3/NS4A protease inhibitor | 0.062 0.019 DBMET00803 | ||
| 0.097 | 0.014 | 0.097 | Matrix metalloproteinase 1 inhibitor | |||
| 0.129 | 0.048 | 0.129 | Caspase 3 inhibitor | |||
| 0.223 | 0.145 | 0.25 | Cholesterol antagonist | 0.25 0.125 DBMET00803 | DBMET00803 | |
| 0.186 | 0.109 | 0.186 | Free radical scavenger | 0.163 0.131 DBMET00803 | ||
| 0.094 | 0.018 | 0.094 | Collagenase 3 inhibitor | |||
| 0.084 | 0.01 | 0.084 | Farnesyltransferase inhibitor | 0.046 0.032 DBMET00803 | ||
| 0.104 | 0.03 | 0.104 | Metalloproteinase-9 inhibitor | |||
| 0.118 | 0.045 | 0.118 | Adenylate kinase inhibitor | 0.111 0.052 DBMET00803 | ||
| 0.094 | 0.021 | 0.227 | NMDA receptor agonist | 0.227 0.004 DBMET00803 | DBMET00803 | |
| 0.123 | 0.051 | 0.137 | Chelator | 0.137 0.041 DBMET00803 | DBMET00803 | |
| 0.106 | 0.035 | 0.106 | Metalloproteinase-2 inhibitor | 0.075 0.059 DBMET00803 | ||
| 0.082 | 0.015 | 0.082 | Elastase inhibitor | 0.049 0.043 DBMET00803 | ||
| 0.101 | 0.036 | 0.104 | Factor XII inhibitor | 0.104 0.034 DBMET00803 | DBMET00803 | |
| 0.069 | 0.004 | 0.086 | Glutamate (mGluR8) antagonist | 0.086 0.003 DBMET00803 | DBMET00803 | |
| 0.08 | 0.02 | 0.08 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.067 | 0.008 | 0.1 | Membrane dipeptidase inhibitor | 0.1 0.004 DBMET00803 | DBMET00803 | |
| 0.073 | 0.018 | 0.073 | Prolactin release inhibitor | 0.072 0.019 DBMET00803 | ||
| 0.078 | 0.023 | 0.078 | Cathepsin E inhibitor | 0.078 0.024 DBMET00803 | ||
| 0.057 | 0.003 | 0.057 | Aminopeptidase P inhibitor | 0.037 0.006 DBMET00803 | ||
| 0.068 | 0.016 | 0.068 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.06 | 0.008 | 0.06 | Angiotensin AT2 receptor antagonist | 0.051 0.009 DBMET00803 | ||
| 0.063 | 0.013 | 0.063 | Collagenase inhibitor | |||
| 0.067 | 0.019 | 0.067 | Alpha-mannosidase inhibitor | 0.051 0.041 DBMET00803 | ||
| 0.091 | 0.043 | 0.097 | Chymotrypsin inhibitor | 0.097 0.038 DBMET00803 | DBMET00803 | |
| 0.107 | 0.06 | 0.121 | GABA C receptor agonist | 0.121 0.049 DBMET00803 | DBMET00803 | |
| 0.135 | 0.089 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.073 DBMET00803 | DBMET00803 | |
| 0.135 | 0.088 | 0.207 | Thiol protease inhibitor | 0.207 0.037 DBMET00803 | DBMET00803 | |
| 0.062 | 0.016 | 0.062 | Mannosidase inhibitor | |||
| 0.081 | 0.037 | 0.081 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 DBMET00803 | ||
| 0.082 | 0.04 | 0.087 | Thrombin inhibitor | 0.087 0.035 DBMET00803 | DBMET00803 | |
| 0.085 | 0.044 | 0.085 | Interferon agonist | |||
| 0.093 | 0.053 | 0.145 | Opioid antagonist | 0.145 0.027 DBMET00803 | DBMET00803 | |
| 0.061 | 0.022 | 0.061 | Vanilloid 2 antagonist | |||
| 0.052 | 0.015 | 0.052 | Angiotensin AT1 receptor antagonist | |||
| 0.067 | 0.03 | 0.079 | Ribonucleoside-diphosphate reductase inhibitor | 0.079 0.025 DBMET00803 | DBMET00803 | |
| 0.059 | 0.024 | 0.098 | Neurotensin receptor antagonist | 0.098 0.014 DBMET00803 | DBMET00803 | |
| 0.045 | 0.01 | 0.045 | Angiotensin II receptor antagonist | |||
| 0.055 | 0.021 | 0.055 | Oxytocin agonist | 0.045 0.027 DBMET00803 | ||
| 0.067 | 0.033 | 0.079 | Ribonucleotide reductase inhibitor | 0.079 0.027 DBMET00803 | DBMET00803 | |
| 0.041 | 0.008 | 0.041 | LFA antagonist | 0.026 0.022 DBMET00803 | ||
| 0.204 | 0.171 | 0.204 | Vasodilator, peripheral | 0.195 0.181 DBMET00803 | ||
| 0.058 | 0.026 | 0.058 | Metalloproteinase-3 inhibitor | |||
| 0.042 | 0.011 | 0.042 | Carboxypeptidase B inhibitor | |||
| 0.047 | 0.017 | 0.082 | Kainate receptor agonist | 0.082 0.004 DBMET00803 | DBMET00803 | |
| 0.048 | 0.019 | 0.049 | Integrin alpha5beta1 antagonist | 0.049 0.019 DBMET00803 | DBMET00803 | |
| 0.072 | 0.044 | 0.072 | Elastase 1 inhibitor | 0.063 0.057 DBMET00803 | ||
| 0.049 | 0.022 | 0.133 | Dipeptidyl peptidase IV inhibitor | 0.133 0.004 DBMET00803 | DBMET00803 | |
| 0.049 | 0.022 | 0.049 | Growth hormone release inhibitor | |||
| 0.057 | 0.03 | 0.127 | Dipeptidyl peptidase inhibitor | 0.127 0.005 DBMET00803 | DBMET00803 | |
| 0.089 | 0.063 | 0.089 | Falcipain inhibitor | |||
| 0.043 | 0.019 | 0.081 | Calcitonin receptor agonist | 0.081 0.012 DBMET00803 | DBMET00803 | |
| 0.086 | 0.063 | 0.086 | Falcipain 2 inhibitor | |||
| 0.066 | 0.043 | 0.151 | Opioid delta receptor antagonist | 0.151 0.019 DBMET00803 | DBMET00803 | |
| 0.084 | 0.061 | 0.099 | Hematopoietic | 0.099 0.037 DBMET00803 | DBMET00803 | |
| 0.07 | 0.048 | 0.07 | Phosphofructokinase-1 inhibitor | |||
| 0.048 | 0.026 | 0.048 | Dihydroorotase inhibitor | |||
| 0.066 | 0.048 | 0.101 | Glutamate (mGluR6) antagonist | 0.101 0.01 DBMET00803 | DBMET00803 | |
| 0.07 | 0.053 | 0.07 | Phospholipase D inhibitor | |||
| 0.04 | 0.023 | 0.042 | Nicotinic receptor beta4 subunit antagonist | 0.042 0.021 DBMET00803 | DBMET00803 | |
| 0.18 | 0.164 | 0.18 | Transcription factor STAT3 inhibitor | |||
| 0.118 | 0.102 | 0.118 | Cytidine deaminase inhibitor | |||
| 0.055 | 0.039 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.035 | 0.019 | 0.05 | Caspase 2 inhibitor | 0.05 0.012 DBMET00803 | DBMET00803 | |
| 0.061 | 0.046 | 0.069 | Caspase 9 inhibitor | 0.069 0.033 DBMET00803 | DBMET00803 | |
| 0.06 | 0.046 | 0.06 | Heme oxygenase stimulant | |||
| 0.023 | 0.01 | 0.023 | Neuraminidase (Influenza B) inhibitor | |||
| 0.113 | 0.101 | 0.14 | Lipid peroxidase inhibitor | 0.14 0.075 DBMET00803 | DBMET00803 | |
| 0.024 | 0.012 | 0.024 | Geranylgeranyltransferase I inhibitor | |||
| 0.039 | 0.028 | 0.039 | GABA uptake inhibitor | |||
| 0.019 | 0.008 | 0.019 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.057 | 0.047 | 0.057 | Neuraminidase inhibitor | |||
| 0.141 | 0.131 | 0.158 | P-glycoprotein inhibitor | 0.158 0.105 DBMET00803 | DBMET00803 | |
| 0.029 | 0.019 | 0.029 | Bradykinin B2 receptor agonist | 0.029 0.02 DBMET00803 | ||
| 0.065 | 0.056 | 0.09 | Histidine decarboxylase inhibitor | 0.09 0.036 DBMET00803 | DBMET00803 | |
| 0.161 | 0.152 | 0.198 | Antioxidant | 0.198 0.115 DBMET00803 | DBMET00803 | |
| 0.031 | 0.024 | 0.045 | Glutamate (mGluR3) agonist | 0.045 0.006 DBMET00803 | DBMET00803 | |
| 0.103 | 0.097 | 0.103 | M17 leucyl aminopeptidase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Integrin beta2 antagonist | |||
| 0.043 | 0.042 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.03 DBMET00803 | DBMET00803 | |
| 0.014 | 0.013 | 0.016 | Dipeptidyl peptidase VIII inhibitor | 0.016 0.009 DBMET00803 | DBMET00803 | |
| 0.01 | 0.009 | 0.01 | Carboxypeptidase B2 inhibitor | |||
| 0.057 | 0.058 | 0.113 | Opioid mu receptor antagonist | 0.113 0.027 DBMET00803 | DBMET00803 | |
| 0.102 | 0.103 | 0.165 | Cathepsin H inhibitor | 0.165 0.037 DBMET00803 | DBMET00803 | |
| 0.08 | 0.082 | 0.154 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.154 0.026 DBMET00803 | DBMET00803 | |
| 0.034 | 0.037 | 0.035 | Toll-Like receptor 2 agonist | 0.035 0.034 DBMET00803 | DBMET00803 | |
| 0.024 | 0.028 | 0.03 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.03 0.014 DBMET00803 | DBMET00803 | |
| 0.045 | 0.05 | 0.049 | CD45 antagonist | 0.049 0.037 DBMET00803 | DBMET00803 | |
| 0.035 | 0.041 | 0.043 | Integrin alpha1beta1 antagonist | 0.043 0.015 DBMET00803 | DBMET00803 | |
| 0.05 | 0.058 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 DBMET00803 | DBMET00803 | |
| 0.012 | 0.019 | 0.018 | Dipeptidyl peptidase IX inhibitor | 0.018 0.009 DBMET00803 | DBMET00803 | |
| 0.027 | 0.036 | 0.037 | Dipeptidyl peptidase II inhibitor | 0.037 0.017 DBMET00803 | DBMET00803 | |
| 0.03 | 0.039 | 0.048 | Glutamate (mGluR3) antagonist | 0.048 0.013 DBMET00803 | DBMET00803 | |
| 0.055 | 0.065 | 0.067 | Trypsin inhibitor | 0.067 0.036 DBMET00803 | DBMET00803 | |
| 0.104 | 0.114 | 0.161 | Histone deacetylase SIRT1 inhibitor | 0.161 0.053 DBMET00803 | DBMET00803 | |
| 0.093 | 0.107 | 0.169 | Cell adhesion inhibitor | 0.169 0.036 DBMET00803 | DBMET00803 | |
| 0.066 | 0.084 | 0.079 | Opioid kappa receptor antagonist | 0.079 0.059 DBMET00803 | DBMET00803 | |
| 0.033 | 0.053 | 0.057 | GP IIb/IIIa receptor antagonist | 0.057 0.029 DBMET00803 | DBMET00803 | |
| 0.072 | 0.095 | 0.087 | Protease inhibitor | 0.087 0.077 DBMET00803 | DBMET00803 | |
| 0.007 | 0.03 | 0.074 | Integrin alpha4beta1 antagonist | 0.074 0.004 DBMET00803 | DBMET00803 | |
| 0.009 | 0.034 | 0.045 | Kainate receptor 1 antagonist | 0.045 0.006 DBMET00803 | DBMET00803 | |
| 0.054 | 0.08 | 0.097 | Cathepsin G inhibitor | 0.097 0.034 DBMET00803 | DBMET00803 | |
| 0.166 | 0.192 | 0.192 | Neuropeptide Y2 antagonist | 0.192 0.135 DBMET00803 | DBMET00803 | |
| 0.023 | 0.051 | 0.044 | Somatostatin 1 antagonist | 0.044 0.024 DBMET00803 | DBMET00803 | |
| 0.014 | 0.042 | 0.035 | Somatostatin 5 antagonist | 0.035 0.021 DBMET00803 | DBMET00803 | |
| 0.01 | 0.041 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.013 DBMET00803 | DBMET00803 | |
| 0.04 | 0.071 | 0.074 | Glucagon-like peptide 1 agonist | 0.074 0.039 DBMET00803 | DBMET00803 | |
| 0.029 | 0.061 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.02 DBMET00803 | DBMET00803 | |
| 0.037 | 0.07 | 0.126 | Argininosuccinate synthase inhibitor | 0.126 0.014 DBMET00803 | DBMET00803 | |
| 0.101 | 0.134 | 0.167 | Cell wall synthesis inhibitor | 0.167 0.05 DBMET00803 | DBMET00803 | |
| 0.057 | 0.091 | 0.073 | Glycine receptor agonist | 0.073 0.049 DBMET00803 | DBMET00803 | |
| 0.013 | 0.048 | 0.023 | Tryptophan hydroxylase 1 inhibitor | 0.023 0.005 DBMET00803 | DBMET00803 | |
| 0.017 | 0.055 | 0.03 | Trypsin I inhibitor | 0.03 0.026 DBMET00803 | DBMET00803 | |
| 0.017 | 0.054 | 0.142 | Glutamate (mGluR1) agonist | 0.142 0.003 DBMET00803 | DBMET00803 | |
| 0.018 | 0.06 | 0.17 | Integrin antagonist | 0.17 0.009 DBMET00803 | DBMET00803 | |
| 0.008 | 0.05 | 0.067 | VLA-4 antagonist | 0.067 0.009 DBMET00803 | DBMET00803 | |
| 0.009 | 0.052 | 0.135 | Integrin alpha4 antagonist | 0.135 0.005 DBMET00803 | DBMET00803 | |
| 0.025 | 0.079 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DBMET00803 | DBMET00803 | |
| 0.014 | 0.071 | 0.051 | Kainate receptor 2 antagonist | 0.051 0.015 DBMET00803 | DBMET00803 | |
| 0.16 | 0.218 | 0.342 | Immunomodulator | 0.342 0.063 DBMET00803 | DBMET00803 | |
| 0.094 | 0.153 | 0.131 | Acetylcholine M1 receptor antagonist | 0.131 0.094 DBMET00803 | DBMET00803 | |
| 0.106 | 0.168 | 0.246 | DNA methyltransferase I inhibitor | 0.246 0.049 DBMET00803 | DBMET00803 | |
| 0.034 | 0.096 | 0.069 | Carbamoyl phosphate synthetase inhibitor | 0.069 0.035 DBMET00803 | DBMET00803 | |
| 0.011 | 0.076 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.021 DBMET00803 | DBMET00803 | |
| 0.055 | 0.121 | 0.107 | Cell adhesion molecule inhibitor | 0.107 0.03 DBMET00803 | DBMET00803 | |
| 0.015 | 0.084 | 0.058 | Kainate receptor antagonist | 0.058 0.017 DBMET00803 | DBMET00803 | |
| 0.02 | 0.091 | 0.04 | Erythropoietin receptor agonist | 0.04 0.028 DBMET00803 | DBMET00803 | |
| 0.008 | 0.079 | 0.027 | Somatostatin 2 antagonist | 0.027 0.021 DBMET00803 | DBMET00803 | |
| 0.111 | 0.188 | 0.247 | Insulin sensitizer | 0.247 0.036 DBMET00803 | DBMET00803 | |
| 0.028 | 0.106 | 0.047 | Glutamate (mGluR4) antagonist | 0.047 0.024 DBMET00803 | DBMET00803 | |
| 0.069 | 0.148 | 0.15 | Nav1.4 sodium channel blocker | 0.15 0.034 DBMET00803 | DBMET00803 | |
| 0.024 | 0.103 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.026 DBMET00803 | DBMET00803 | |
| 0.009 | 0.088 | 0.082 | Glutamate (mGluR1a) agonist | 0.082 0.004 DBMET00803 | DBMET00803 | |
| 0.077 | 0.16 | 0.101 | Factor V inhibitor | 0.101 0.067 DBMET00803 | DBMET00803 | |
| 0.179 | 0.264 | 0.647 | Analgesic | 0.647 0.019 DBMET00803 | DBMET00803 | |
| 0.032 | 0.12 | 0.077 | Nitric oxide donor | 0.077 0.025 DBMET00803 | DBMET00803 | |
| 0.068 | 0.163 | 0.108 | Microtubule formation inhibitor | 0.108 0.077 DBMET00803 | DBMET00803 | |
| 0.072 | 0.168 | 0.14 | Cyclooxygenase 3 inhibitor | 0.14 0.057 DBMET00803 | DBMET00803 | |
| 0.027 | 0.14 | 0.042 | Glutamate (mGluR group III) antagonist | 0.042 0.033 DBMET00803 | DBMET00803 | |
| 0.004 | 0.122 | 0.017 | Integrin beta7 antagonist | 0.017 0.016 DBMET00803 | DBMET00803 | |
| 0.068 | 0.19 | 0.144 | Folate antagonist | 0.144 0.025 DBMET00803 | DBMET00803 | |
| 0.089 | 0.22 | 0.246 | DNA methylase inhibitor | 0.246 0.051 DBMET00803 | DBMET00803 | |
| 0.083 | 0.225 | 0.187 | Growth hormone agonist | 0.187 0.064 DBMET00803 | DBMET00803 | |
| 0.065 | 0.213 | 0.221 | Psychostimulant | 0.221 0.07 DBMET00803 | DBMET00803 | |
| 0.02 | 0.181 | 0.039 | Glutamate (mGluR group III) agonist | 0.039 0.035 DBMET00803 | DBMET00803 | |
| 0.106 | 0.292 | 0.243 | Transcription factor NF kappa B inhibitor | 0.243 0.132 DBMET00803 | DBMET00803 | |
| 0.079 | 0.271 | 0.292 | Platelet antagonist | 0.292 0.055 DBMET00803 | DBMET00803 | |
| 0.04 | 0.232 | 0.081 | Aminoacyl-tRNA synthetase inhibitor | 0.081 0.076 DBMET00803 | DBMET00803 | |
| 0.029 | 0.249 | 0.144 | Inducible nitric-oxide synthase inhibitor | 0.144 0.018 DBMET00803 | DBMET00803 | |
| 0.005 | 0.234 | 0.13 | Kinesin antagonist | 0.13 0.005 DBMET00803 | DBMET00803 | |
| 0.005 | 0.234 | 0.13 | Kinesin-like protein 1 inhibitor | 0.13 0.005 DBMET00803 | DBMET00803 | |
| 0.015 | 0.26 | 0.11 | Glutamate receptor agonist | 0.11 0.031 DBMET00803 | DBMET00803 | |
| 0.106 | 0.385 | 0.168 | Peptidyltransferase inhibitor | 0.168 0.151 DBMET00803 | DBMET00803 | |
| 0.124 | 0.416 | 0.281 | Cyclophilin D inhibitor | 0.281 0.18 DBMET00803 | DBMET00803 | |
| 0.025 | 0.362 | 0.134 | Nitric-oxide synthase inhibitor | 0.134 0.03 DBMET00803 | DBMET00803 | |
| 0.038 | 0.596 | 0.124 | NOS3 expression enhancer | 0.124 0.107 DBMET00803 | DBMET00803 | |
| 0.019 | 0.627 | 0.113 | ErbB-3 antagonist | 0.113 0.033 DBMET00803 | DBMET00803 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |